EUVIMEDEUVIMED entdecken
Open Access

mTORC1-TFEB/TFE3 signaling is associated with bile acid diversification during hepatic metabolic adaptation

Alex Zaufel iD, Wenfei Sun iD, Nunzia Pastore, Ulrike Taschler iD, Carina Wagner iD, Hubert Hackl iD, Judith Sommer, Dagmar Silbert-Wagner, Jan G Hengstler, Brigitte Begher-Tibbe iD, Rudolf Stauber iD, Dagmar Kolb und 16 weitere

Science Advances · 2026

DOI: 10.1126/sciadv.aee1905 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Alex Zaufel und 27 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz; Graz, Austria. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Bile Acids and Salts, Signal Transduction. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, Associazione Italiana Ricerca sul Cancro, Austrian Science Fund FWF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanistic target of rapamycin complex 1 (mTORC1) integrates nutrient and hormonal cues to regulate hepatic lipid metabolism with major implications for metabolic dysfunction-associated steatotic liver disease (MASLD). Here, we show that altered hepatic mTORC1–TFEB/TFE3 signaling is associated with coordinated remodeling of bile acid (BA) metabolism during metabolic adaptation. Our data support a model in which cross-talk between mTORC1 and TFEB/TFE3 is associated with divergent regulation of bile acid synthesis and transformation. Depending on the mTORC1 signaling state, changes in hepatic Cyp2c70 and Cyp8b1 expression, together with altered cholesterol trafficking, were associated with shifts toward non–12-OH or 12-OH bile acid species. These effects were attenuated or reversed by Tfe3 deletion or rapamycin treatment. Furthermore, protein restriction (which inhibits mTORC1) similarly reshaped the BA profile in mice and correlated with improved metabolic outcomes in MASLD patients. Together, these findings uncover BA homeostasis as an integral component of the metabolic adaptations orchestrated by mTORC1, underscoring a link between nutrient signaling and metabolic liver disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mechanistic Target of Rapamycin Complex 1Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsBile Acids and SaltsSignal TransductionLiverAdaptation, PhysiologicalAnimalsMiceHumansFatty LiverMetabolic Reprogramming

Substanzen

Mechanistic Target of Rapamycin Complex 1Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsBile Acids and SaltsTcfe3 protein, mouseTcfeb protein, mouse

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz; Graz, Austria.
  • Institute of Food, Nutrition and Health, ETH Zurich, Schwerzenbach, Switzerland.
  • Division of Endocrinology, Department of Medicine, Stanford University School of Medicine, Stanford University, Palo Alto, CA, USA.
  • Telethon Institute of Genetics and Medicine (TIGEM); Pozzuoli, Italy; Medical Genetics Unit, Department of Medical and Translational Science, Federico II University, Naples, Italy.
  • Department of Translational Medicine, Medical Genetics, Federico II University, Naples, Italy.
  • Institute of Molecular Biosciences, University of Graz, Graz, Austria.

ORCID-Profile: Alex Zaufel, Wenfei Sun, Ulrike Taschler, Carina Wagner, Hubert Hackl, Brigitte Begher-Tibbe, Rudolf Stauber, Martin Troetzmueller, Benjamin Gottschalk, Chelsea Thorsheim, Eva-Lena Stange, Mathias W Hornef, Olga Pivovarova-Ramich, Andreas F H Pfeiffer, Kylie P Matchett, Anne Loft, Stephan Herzig, Neil C Henderson, Andrea Ballabio, Zoltan Arany, Peter Fickert, Tarek Moustafa

Förderung

  • Wellcome Trust
  • Associazione Italiana Ricerca sul Cancro
  • Austrian Science Fund FWF
  • Wellcome Trust Senior Research Fellowship in Clinical Science
  • Collaborative Research Centers CRC1382
  • CRC/TRR 359
  • European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program

Zitieren

APA

Zaufel, A., Sun, W., Pastore, N., Taschler, U., Wagner, C., Hackl, H., Sommer, J., Silbert-Wagner, D., Hengstler, J. G., Begher-Tibbe, B., Stauber, R., Kolb, D., Troetzmueller, M., Gottschalk, B., Thorsheim, C., Stange, E. L., Hornef, M. W., Pivovarova-Ramich, O., Pfeiffer, A. F. H., …, & Moustafa, T. (2026). mTORC1-TFEB/TFE3 signaling is associated with bile acid diversification during hepatic metabolic adaptation. Science Advances. https://doi.org/10.1126/sciadv.aee1905

Vancouver

Zaufel A, Sun W, Pastore N, Taschler U, Wagner C, Hackl H, et al. mTORC1-TFEB/TFE3 signaling is associated with bile acid diversification during hepatic metabolic adaptation. Science Advances. 2026. doi:10.1126/sciadv.aee1905

BibTeX
@article{Zaufel2026,
  author = {Zaufel, Alex and Sun, Wenfei and Pastore, Nunzia and Taschler, Ulrike and Wagner, Carina and Hackl, Hubert and Sommer, Judith and Silbert-Wagner, Dagmar and Hengstler, Jan G and Begher-Tibbe, Brigitte and Stauber, Rudolf and Kolb, Dagmar and Troetzmueller, Martin and Gottschalk, Benjamin and Thorsheim, Chelsea and Stange, Eva-Lena and Hornef, Mathias W and Pivovarova-Ramich, Olga and Pfeiffer, Andreas F H and Matchett, Kylie P and Loft, Anne and Herzig, Stephan and Henderson, Neil C and Ballabio, Andrea and Arany, Zoltan and Wolfrum, Christian and Fickert, Peter and Moustafa, Tarek},
  title = {mTORC1-TFEB/TFE3 signaling is associated with bile acid diversification during hepatic metabolic adaptation},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aee1905}
}
Kostenlos starten →